Racial differences in the response to drugs--pointers to genetic differences

N Engl J Med. 2001 May 3;344(18):1394-6. doi: 10.1056/NEJM200105033441811.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adrenergic Antagonists / metabolism
  • Adrenergic Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Carbazoles / metabolism
  • Carbazoles / therapeutic use*
  • Carvedilol
  • Cytochrome P-450 Enzyme System / genetics*
  • Enalapril / therapeutic use*
  • Heart Failure / drug therapy*
  • Heart Failure / ethnology*
  • Hospitalization
  • Humans
  • Mortality
  • Propanolamines / metabolism
  • Propanolamines / therapeutic use*
  • Racial Groups / genetics*

Substances

  • Adrenergic Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Carbazoles
  • Propanolamines
  • Carvedilol
  • Enalapril
  • Cytochrome P-450 Enzyme System